SINTX Technologies Files Multiple New U.S. and International Patent Applications

This week SINTX Technoloiges announced multiple U.S. and international patent applications for development of new technologies utilizing the company’s silicon nitride. “The innovative application of SINTX’s silicon nitride promises new tools to improve our public health response to COVID-19 and other viruses,” said Kelvyn Cullimore, president and CEO of BioUtah. SINTX has found that its […]

Read More

Biden Supports IP Waiver for COVID-19 Vaccines

The Biden administration has announced that they will back a waiver of the WTO Trade-Related Aspects of Intellectual Property Rights (TRIPS) agreement so that any country can produce vaccines without worrying about patent infringement. This has the potential to drastically hinder global vaccine manufacturing and distribution and sets a dangerous precedent for future pandemics. The […]

Read More

U.S. Study of DiscGenics IDCT Achieves One-Year Follow-Up Milestone

DiscGenics, a clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine,  has completed enrollment in its Japanese safety study of Injectable Discogenic Cell Therapy (IDCT) for lumbar disc degeneration, a major cause of chronic low back pain. This Japanese 38-subject […]

Read More

Co-Diagnostics, Inc. JV CoSara Diagnostics Recognized for Work Combating COVID-19 Surge in India

Co-Diagnostics’ Indian manufacturing facility, CoSara Diagnostics Pvt. Ltd. (“CoSara,” or the “JV”, a Joint Venture with Synbiotics Ltd) has been featured in recent press highlighting its actions to provide COVID-19 diagnostics as a surge of infections has led to the world’s worst COVID-19 outbreak since the pandemic began. The article in the Times of India […]

Read More

Canary Speech and Constant Companion Partner to Help Diagnose Behavioral Health Issues

Utah Business Magazine has highlighted a new partnership between Constant Companion and Canary Speech to study how voice technology can be used to identify human conditions in specific populations. Canary Speech will analyze the data with its patented speech digital biomarker technology, used to diagnose behavioral conditions and other diseases. Constant Companion will be utilizing its […]

Read More

UNIVERSITY OF UTAH, ARUP, AND TECHCYTE DEVELOP NANOSPOT.AI, A NEW ULTRA-FAST TEST FOR COVID-19 ANTIBODIES

The University of Utah (the U), ARUP Laboratories, and Techcyte Inc. announced that they have formed a partnership to develop NanoSpot.AI, a less than five-minute, easy-to-administer COVID-19 antibody test. NanoSpot.AI is estimated to be significantly less expensive to manufacture than other antibody tests, so it has the potential to be much more affordable and extend […]

Read More